MyMD Pharmaceuticals Inc.

02/23/2022 | Press release | Archived content

MyMD Pharmaceuticals® Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan